Microfluidic device and uses thereof

Doron Gerber (Inventor)

Research output: Patent


The present disclosure provides microfluidic test platforms, systems, and methods for manufacturing the disclosed test platforms. The present disclosure further provides uses of the disclosed microfluidic test platforms in personalized medicine. Specifically, in providing prognostic and therapeutic methods for determining drug sensitivity and optimizing treatment regimen for subjects suffering from a pathologic disorder, specifically, cancer.
Original languageEnglish
Patent numberUS20210354140A1
StatePublished - 18 Nov 2021

Bibliographical note

US Patent App. 17/321,142


Dive into the research topics of 'Microfluidic device and uses thereof'. Together they form a unique fingerprint.

Cite this